Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on Friday.
Source link
Ozempic maker Novo Nordisk boots CEO over stock-price fall
- Advertisement -